FDA-Approved Botulinum Toxin Preparations (1989–2024) | Clinical Overview
Автор: Dr. Sahire – Aesthetic Injection Academy
Загружено: 2025-04-27
Просмотров: 223
Explore the complete list of FDA-approved botulinum toxin preparations, from the first approval of Botox® in 1989, to the most recent approval of Letybo® in 2024.
This overview includes:
• Botox® (1989, United States – Allergan)
• Myobloc® (2000, United States – Solstice Neurosciences)
• Dysport® (2009, United Kingdom – Ipsen)
• Xeomin® (2010, Germany – Merz Pharmaceuticals)
• Jeuveau® (2019, South Korea – Evolus / Daewoong)
• Daxxify® (2022, United States – Revance Therapeutics)
• Letybo® (2024, South Korea – Hugel)
Each preparation has unique therapeutic and/or aesthetic indications, specific manufacturing origins, and different clinical profiles.
Staying informed about newly approved products is essential for clinical excellence in aesthetic and therapeutic practices.
#BotulinumToxin #Botox #Dysport #Xeomin #Myobloc #Jeuveau #Daxxify #Letybo #FDA #MedicalEducation #AestheticMedicine
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
